G. Schernthaner

Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions

Adnan Sharif, Manfred Hecking, Aiko P. J. de Vries et al. · American Journal of Transplantation · 2014 · 509 citations · Full text

Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML

Karl J. Aichberger, Susanne Herndlhofer, G. Schernthaner et al. · American Journal of Hematology · 2011 · 297 citations

Vascular Disease, Sudden Death, Pharmacotherapy +22

Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors

Peter Valent, Emir Hadzijusufovic, G. Schernthaner et al. · Blood · 2014 · 280 citations · Full text

GUIDE study: double‐blind comparison of once‐daily gliclazide MR and glimepiride in type 2 diabetic patients

G. Schernthaner, André Grimaldi, Umberto Di Mario et al. · European Journal of Clinical Investigation · 2004 · 266 citations

COXSACKIE B, MUMPS, RUBELLA, AND CYTOMEGALOVIRUS SPECIFIC IgM RESPONSES IN PATIENTS WITH JUVENILE-ONSET INSULIN-DEPENDENT DIABETES MELLITUS IN BRITAIN, AUSTRIA, AND AUSTRALIA

J. E. Banatvala, G. Schernthaner, Edith Schober et al. · The Lancet · 1985 · 214 citations

Diabetes Epidemiology, Coxsackie B, Diabetes +3